Biologic-naïve patients with radiographic axial spondyloarthritis who received treatment with ixekizumab reported early and ...

Patients with vs without SARDs receiving SGLT2 inhibitors were linked to greater risks for AEs; the strongest associations ...

The FDA has accepted the sNDA for avatrombopag for the treatment of thrombocytopenia in pediatric patients aged 1 year and ...

Xalnesiran plus an immunomodulator results in a substantial percentage of patients with hepatitis B surface antigen (HBsAg) ...

HealthDay News — The Coronary Risk Score in Women (CORSWO) can predict the risk of major adverse cardiovascular events (MACE) ...

The American Academy of Pediatrics endorses a new algorithm for use in critical congenital heart disease screening.